These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 28976989

  • 21. Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease.
    Fujii H, Yonekura Y, Nakai K, Kono K, Goto S, Nishi S.
    J Steroid Biochem Mol Biol; 2017 Mar; 167():55-60. PubMed ID: 27818277
    [Abstract] [Full Text] [Related]

  • 22. The effect of n-3 fatty acids on levels of methylarginines in patients with end-stage renal disease.
    Svensson M, Frøbert O, Schmidt EB, Jørgensen KA, Simonsen U, Christensen JH.
    J Nephrol; 2010 Mar; 23(4):459-64. PubMed ID: 20349405
    [Abstract] [Full Text] [Related]

  • 23. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
    Jepson RE, Syme HM, Vallance C, Elliott J.
    J Vet Intern Med; 2008 Mar; 22(2):317-24. PubMed ID: 18371026
    [Abstract] [Full Text] [Related]

  • 24. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
    Lindberg J, Martin KJ, González EA, Acchiardo SR, Valdin JR, Soltanek C.
    Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study.
    Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Böger SM, Haller H, Ritz E.
    J Am Soc Nephrol; 2005 Aug; 16(8):2456-61. PubMed ID: 15930091
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.
    Fishbane S, Chittineni H, Packman M, Dutka P, Ali N, Durie N.
    Am J Kidney Dis; 2009 Oct; 54(4):647-52. PubMed ID: 19596163
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antiproteinuric effect of oral paricalcitol in chronic kidney disease.
    Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D.
    Kidney Int; 2005 Dec; 68(6):2823-8. PubMed ID: 16316359
    [Abstract] [Full Text] [Related]

  • 38. Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients.
    Zoccali C, Torino C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Ghiadoni L, Thadhani R, Tripepi G, Mallamaci F.
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):581-589. PubMed ID: 27113290
    [Abstract] [Full Text] [Related]

  • 39. Effects on asymmetric dimethylarginine of HMR 3339, a novel selective estrogen receptor modulator: a 12-week, randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women.
    Verhoeven MO, Teerlink T, Kenemans P, Vogelvang TE, van der Mooren MJ, HMR 3339 Research Group.
    Menopause; 2007 Jul; 14(2):235-42. PubMed ID: 17146377
    [Abstract] [Full Text] [Related]

  • 40. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.